real-time news and commentary for investors
Tuesday, Sep 10
Perrigo gets FDA approval for generic version of Children's Zyrtec allergy syrup
- Perrigo (PRGO +0.3%) says it's landed final approval from the FDA for its abbreviated new drug application for a bubble gum-flavored cetirizine hydrochloride oral solution, the generic version of Children's Zyrtec Allergy Syrup.
- The company plans to begin shipments during the next cough, cold and flu season.